Malcolm Macartney
About
In The Last Decade
Malcolm Macartney
18 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Virology 663
- Infectious Diseases 523
- Molecular Biology 284
- Immunology 217
- Epidemiology 213
Countries citing papers authored by Malcolm Macartney
This map shows the geographic impact of Malcolm Macartney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Macartney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Macartney more than expected).
Fields of papers citing papers by Malcolm Macartney
This network shows the impact of papers produced by Malcolm Macartney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Macartney. The network helps show where Malcolm Macartney may publish in the future.
Co-authorship network of co-authors of Malcolm Macartney
This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm Macartney. A scholar is included among the top collaborators of Malcolm Macartney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm Macartney. Malcolm Macartney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 38 | |
| 3 | 12 | |
| 4 | 4 | |
| 5 | 6 | |
| 6 | 8 | |
| 7 | 14 | |
| 8 | Anaplasmosis in a dog on Vancouver Island. | 1 |
| 9 | 10 | |
| 10 | 5 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 11 | |
| 14 | 5 | |
| 15 | 13 | |
| 16 | Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity breakdown → | 909 |
| 17 | 4 | |
| 18 | 2 | |
| 19 | 21 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.